Hydrophobic Interaction Chromatography Market Trends

Growth Drivers

Growing Development of Monoclonal Antibodies – At least 570 therapeutic mAbs have been researched in clinical trials by commercial businesses around the world, and 79 therapeutic mAbs have been licensed and are currently on the market by the United States Food and Drug Administration (US FDA). Hydrophobic interaction chromatography is an essential part of the development of Mabs, as they are used for its analysis and final purification.
Rising Expenditure on Biopharmaceutical R&D –The increased spending on biopharmaceutical research and development, and production leads to a higher generation of new drugs and treatments. In the developmental stage of these drugs, HIC segregates the target molecules from the complex mixtures and helps them meet the regulatory requirements. In 2021, the 15 major pharmaceutical companies in the United States invested a record around USD 133 billion in R&D, approximately a 44% increase over 2016.
Rising Cases of Cancer–HIC is used for the characterization and quality of control of cancer treatment therapeutic proteins. Therefore, the rising cases of cancer are driving the market growth. Cancer is one of the leading causes of death on the globe. Moreover, every year, around 400 000 children are identified as cancer patients.

Challenges

Hydrophobic Interaction Chromatography is Expensive – HIC has various components, such as chromatography column, detectors, and systems, that is costly to acquire and maintain. Moreover, other consumables, including resin and buffers can also put a burden on the overall expense. Therefore, all these expenditures, particularly for a small organization, are likely to hamper the hydrophobic interaction chromatography market growth.
Lack of highly qualified technicians and researchers
Low adoption of technique in the under-developed countries

Hydrophobic Interaction Chromatography Market: Key Insights

Base Year	2022
Forecast Year	2023-2035
CAGR	~ 10.5%
Base Year Market Size (2022)	~ USD 1.39 Billion
Forecast Year Market Size (2035)	~ USD 4.61 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

Rising development of vaccines and higher investment in biopharma industries are the major factors driving the market growth.

The market size of hydrophobic interaction chromatography is anticipated to attain a CAGR of 10.5% over the forecast period, i.e., 2023 â€“ 2035.

: The major players in the market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, The General Electric Company, Sartorius AG, Tosoh Bioscience Inc., Sepax Technologies, Inc., Merck KGaA., JNC Corporation, and Geno Technology Inc., and Sunresin New Materials Co.Ltd.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by sample, product & services, end user, and by region.

The monoclonal antibodies segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Lack of trainer forces, and high cost of implementation are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

Hydrophobic Interaction Chromatography Market Trends